secukinumab

Italy

Drugs containing this active substance

  • COSENTYX

    Cosentyx is indicated for the treatment of several inflammatory diseases, including plaque psoriasis (in adults, adolescents, and children aged 6 years and older), hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthritis.

    Form: powder for solution for injection

    Active substance Dosage
    secukinumab -

    ATC: L04AC10

    Manufacturer: NOVARTIS EUROPHARM LIMITED